1-4 of 4
Marjolein Lahaye
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Effectiveness and Safety of Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL) in Belgium after 4 Years

Kirsten Saevels, Sylvia Snauwaert, Gaeten Vanstralen, Marc Andre, Fritz Offner, Ariane Maes, Marjolein Lahaye, Ann Janssens
Journal: Blood
Blood (2023) 142 (Supplement 1): 6550.
https://doi.org/10.1182/blood-2023-174762
Published: 2023
Journal Articles

Overall and Subgroup Results from the Third Interim Analysis of FIRE, a Real-World Study of Ibrutinib Treatment for CLL/SLL in France

Caroline Dartigeas, Loic Ysebaert, Pierre Feugier, Alain Delmer, Sandrine Dupuis, Marine Deslandes, Marjolein Lahaye, Veronique Leblond
Journal: Blood
Blood (2022) 140 (Supplement 1): 9906–9907.
https://doi.org/10.1182/blood-2022-155564
Published: 2022
Journal Articles

Effectiveness and Safety of Ibrutinib in Patients with Mantle Cell Lymphoma (MCL) in Belgian Routine Clinical Practice: 3-Year Follow-up

Vibeke Vergote, Sylvia Snauwaert, Kirsten Saevels, Birgit De Beleyr, Marjolein Lahaye, Ariane Maes, Hilde Demuynck, Sarah Debussche, Marc Andre
Journal: Blood
Blood (2022) 140 (Supplement 1): 3661–3662.
https://doi.org/10.1182/blood-2022-158504
Published: 2022
Journal Articles

Evaluation of Experimental Retreatment and Prolonged Therapy with Subcutaneous (SC) Bortezomib in Patients (Pts) with Multiple Myeloma in First or Second Relapse, a Randomized, Controlled, Phase 3 Study

Michele Cavo, MD, Marco Gobbi, MD, Anna Potamianou, MD PhD, Marjolein Lahaye, MSc, Catherine Couturier, PharmD, Evangelos Terpos, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3328.
https://doi.org/10.1182/blood.V128.22.3328.3328
Published: 2016